Literature DB >> 7539110

Disappointments in treating acute leukemia in the elderly.

T J Hamblin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539110     DOI: 10.1056/NEJM199506223322511

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemia.

Authors:  Dianna S Howard; Jane Liesveld; Gordon L Phillips; John Hayslip; Heidi Weiss; Craig T Jordan; Monica L Guzman
Journal:  Leuk Res       Date:  2013-09-08       Impact factor: 3.156

2.  Flexible low-intensity combination chemotherapy for elderly patients with acute myeloid leukemia.

Authors:  Arumugam Manoharan; Annette Trickett; Yiu Lam Kwan; Timothy Brighton
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

Review 3.  Treatment concepts for elderly patients with acute myeloid leukemia.

Authors:  Wolfgang R Sperr; Alexander W Hauswirth; Friedrich Wimazal; Paul Knöbl; Klaus Geissler; Peter Valent
Journal:  Wien Klin Wochenschr       Date:  2003-08-14       Impact factor: 1.704

Review 4.  Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: non-myeloablative preparative regimens and induction of the graft-versus-leukemia effect.

Authors:  A Shimoni; S Giralt; I Khouri; R Champlin
Journal:  Curr Oncol Rep       Date:  2000-03       Impact factor: 5.945

5.  Timed sequential chemotherapy with concomitant granulocyte colony-stimulating factor for high-risk acute myelogenous leukemia: a single arm clinical trial.

Authors:  Xing-Yue He; Paul Elson; Brad Pohlman; Alan Lichtin; Mohamad Hussein; Steve Andresen; Matt Kalaycio
Journal:  BMC Cancer       Date:  2002-05-09       Impact factor: 4.430

6.  p53 status of newly established acute myeloid leukaemia cell lines.

Authors:  A Zheng; K Castren; M Säily; E R Savolainen; P Koistinen; K Vähäkangas
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.